Frede Donskov

225 papers receiving 8.3k citations

Hit Papers

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma 2021 · 183 citations
1830+4+8Years since publication200400600

Peers

Frede Donskov
Comparison fields: 5 of 102
  • Pulmonary and Respiratory Medicine 5.7k
  • Cancer Research 2.4k
  • Oncology 4.2k
  • Immunology 1.5k
  • Molecular Biology 3.3k
Replace Gwénaëlle Gravis with:
Gwénaëlle Gravis France
Gregory M. Lubiniecki United States
Jens Bedke Germany
Martin H. Voss United States
Suman Rao United States
Andrea Fülöp Hungary
Sara Lonardi Italy
Daniel Y.C. Heng Canada
Napoleone Ferrara United States
Corina E. Dutcus United States
Frede Donskov relative to Gwénaëlle Gravis France Gwénaëlle Gravis's profile →
Citations per field
00.5×1.7×
Gwénaëlle Gravis · 1×
Citations per year

Countries citing papers authored by Frede Donskov

Since Specialization
Citations

This map shows the geographic impact of Frede Donskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frede Donskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frede Donskov more than expected).

Fields of papers citing papers by Frede Donskov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frede Donskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frede Donskov. The network helps show where Frede Donskov may publish in the future.

Co-authors

The 25 scholars most cited alongside Frede Donskov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frede Donskov Line = papers co-authored together Frede Donskov links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.

#Work
1
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
Hit paper breakdown →
2013730
2 2009370
3
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
Hit paper breakdown →
2020347
4 2014311
5 2015288
6 2014270
7 2006259
8 2013238
9 2011218
10 2017184
11
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
Hit paper breakdown →
2021183
12 2013182
13 2017176
14 2013170
15 2021160
16 2018153
17 2016125
18 2013113
19 2011110
20 2013107

About Frede Donskov

Frede Donskov is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Economics and Econometrics, having authored 233 papers that have together received 8.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (190 papers), Cancer Genomics and Diagnostics (91 papers), Renal and related cancers (83 papers), Cancer Immunotherapy and Biomarkers (50 papers), Economic and Financial Impacts of Cancer (28 papers), Pancreatic and Hepatic Oncology Research (21 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Multiple and Secondary Primary Cancers (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.7k citations), Cancer Research (2.4k citations), Oncology (4.2k citations), Immunology (1.5k citations) and Molecular Biology (3.3k citations). Frede Donskov has collaborated with scholars based in Denmark, United States and Canada. Frequent co-authors include Hans von der Maase, Toni K. Choueiri, Brian I. Rini, Georg A. Bjarnason, Lori Wood, Daniel Y.C. Heng, Christian Kollmannsberger, Ulka N. Vaishampayan, Sun Young Rha and Niels Marcussen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, European Urology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact